Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FLTN8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,953
Award facts
- Contract value 100% obligated
- $20,953.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,953.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 68 mg Nexplanon implants. This delivery order, issued on January 16, 2026, with an ultimate completion date of February 9, 2026, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no set-aside designation, indicating the contractor competed in an unrestricted procurement environment. The contract is funded entirely by the Defense Logistics Agency's Medical Supply Chain division without identified subcontractors.
This delivery order falls under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion Department of Defense acquisition initiative that establishes regional pharmaceutical prime vendors to supply military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC valued at $499,999,999 through December 31, 2036, under this framework, positioning it as a critical supplier for DoD medical operations. The company's demonstrated capability across a diverse pharmaceutical portfolio—including specialty products, biologics, vaccines, and routine medications—supports the military healthcare system's comprehensive pharmaceutical supply requirements globally.
Quick answers
Who was awarded contract SPE2DR26FLTN8?
SPE2DR26FLTN8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FLTN8 worth?
The government has obligated $20,953 on SPE2DR26FLTN8.
Is contract SPE2DR26FLTN8 an order under another contract?
Yes. SPE2DR26FLTN8 is a delivery order under SPE2DR25D9766, an indefinite delivery contract.
Was contract SPE2DR26FLTN8 competed?
The extent of competition for SPE2DR26FLTN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award